Project Grant HT94252410730
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
This federal Project Grant award of $2,469,162.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Wake Forest University Health Sciences (WFUHS) to investigate medical solutions for the battlefield and transform healthcare for military service members, veterans, and the public. The award will fund research on using allograft versus autograft to improve timely return to duty following nonunion, with a...
This $380,785 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The award provides funding for a 3-year research project titled "MICROPARTICLE DELIVERY OF CHEMOKINE MUTEINS GUIDING CHEMOKINE RECEPTOR ENGINEERED TREG FOR TOLERANCE INDUCTION AFTER VASCULAR COMPOSITE ALLOGRAFT TRANSPLANT." The project aims to develop a microparticle-based delivery system to administer...
This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
This federal Project Grant award for $278,418.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research on the delivery of chemokine muteins (modified chemokine proteins) to guide engineered regulatory T cells (Tregs) for inducing immune tolerance after vascular composite allograft transplants. The research is being conducted by the Rector & Visitors Of The University Of Virginia, a leading academic institution with...
The University of Pittsburgh has been awarded a $540,800 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on microparticle delivery of chemokine muteins guiding chemokine receptor engineered Treg for tolerance induction after vascular composite allograft transplant. The 3-year award, which runs from September 15, 2024 to September 14, 2027, will support innovative scientific studies aimed at developing novel...
This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...
This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...
This federal Project Grant award of $1,799,493.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Wake Forest University Health Sciences (WFUHS) located in Winston-Salem, North Carolina. The grant supports research to develop PEDF-enriched exosomes for improving urethral sphincter function after radical prostatectomy. WFUHS, a leading academic medical research institution, will leverage its expertise in translational...